TMCnet News
Iovance Biotherapeutics to Present at the 2018 Cantor Global Healthcare ConferenceSAN CARLOS, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that Timothy Morris, CFO, will present at the 2018 Cantor Global Healthcare Conference in New York, NY on Tuesday, October 2, 2018 at 2:15 p.m. ET in New York, NY. A live audio webcast of the presentation will be available by visiting the Investors section of Iovance Biotherapeutics' website at http://ir.iovance.com. A replay of the webcast will be archived on Iovance Biotherapeutics’ website for 30 days following the prsentation. About Iovance Biotherapeutics, Inc. Investor Relations Contact: |